A clinicopathologic analysis of colorectal cancers diagnosed by histology of colonoscopy-derived specimens in Lagos, Nigeria
Makale Kenar Çubuğu
Ana Makale İçeriği
Öz
Introduction: Colorectal cancer (CRC) is one of the
leading causes of cancer-related deaths in Nigeria.
Emerging data indicate there is a gradual increment
in the uptake of colonoscopy as an essential tool in
CRC diagnosis in the country. This article seeks to
document the clinico-pathologic patterns of CRC that
were diagnosed via histology of colonoscopy-derived
samples and highlight differences and relationships
in site-specific disease.
Methods: This was a retrospective study over a
period of five years, carried out in two private medical
centres in Lagos State, Nigeria. Patients who had a
diagnosis of CRC from the histology of colonoscopy
derived tissue samples were included in the study.
The records were then scoured for the demographic,
clinical presentation and pathology data
Results: A total of 84 subjects were included in this
study and there were 47 (56%) males and 37 (44%)
females with a male to female ratio of 1.3:1. The
mean age and standard deviation was 56.6 ± 13.9
years. Thirty seven subjects (44%) were aged 50
years and below. Patients with left-sided disease
constituted the majority 64 (76.2%) in this series and
the most common colonic sub-site was the rectum/
rectosigmoid 35 (41.7%). Bleeding per rectum was
by far the commonest presenting complaint 45
(53.6%) and this was the only symptom that was
significantly associated with left-sided CRC (p=
0.003) while right-sided lesions were associated with
unexplained anemia (p= 0.032) and abdominal pain/
discomfort (p= 0.02). Adenocarcinoma was the most
frequently encountered histological subtype 61
(72.6%).
Conclusion: The study finds that a high proportion
of subjects afflicted with CRC are in the young age
groups. Hematochezia was the most common
presenting complaint and rectal/rectosigmoid the most
common colonic location of CRC lesions. A significant
relationship was found between sidedness and
specific symptoms at presentation.
Makale Ayrıntıları
Bölüm
Referanslar
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A, et al. Global cancer
statistics 2020: GLOBOCAN estimates of
incidence and mortality worldwide for 36 cancers
in 185 countries. CA Cancer J Clin 2021; 71(3):
-249. doi: 10.3322/caac.21660
Colonoscopy and colorectal cancers in Lagos, Nigeria 137
Olorunda R and Abdulkareem FB. Fifty-three
years of reporting colorectal cancer in Nigerians
- a systematic review of the published literature.
The Nigerian Postgraduate Medical J 2014; 21(1):
-73. PMID: 24956622
Alatise OI, Olasehinde O, Olokoba AB, et al.
Colorectal cancer screening guidelines for
Nigeria in 2019. Niger J Gastroenterol Hepatol
; 11: 42-55. doi: 10.4103/
NJGH.NJGH_15_20
Schreuders EH, Ruco A, Rabeneck L, et al.
Colorectal Cancer Screening: A Global Overview
of Existing Programmes. Gut 2015; 64(10): 1637-
doi: 10.1136/gutjnl-2014-309086
Musa Y, Mohammed MF, Muhammad NO, et al.
Clinical, endoscopic and histological profile of
colorectal cancers seen on colonoscopy in Kano,
North-Western Nigeria. Niger Postgrad Med J
; 28: 22-26. doi: 10.4103/npmj.npmj_288_20
Oluyemi A, Odeghe E and Adeniyi O. Colonoscopy
findings in lower gastrointestinal bleeding in Lagos:
A comparative study based on age. Niger J Clin
Pract 2020; 23(12): 1656-1659. doi: 10.4103/
njcp.njcp_341_20
Umana IOM, Obaseki DE and Ekane VJ. The
clinicopathological features of lower
gastrointestinal tract endoscopic biopsies in Benin
City, Nigeria. Saudi Surg J 2017; 5: 9-20. doi:
4103/2320-3846.204418
Picardo NG, Ajayi NA and Ajayi IA. Lower
gastrointestinal endoscopy in Enugu, Nigeria: An
experience with 151 cases. Niger J Gastroenterol
Hepatol 2017; 9: 15 20.
Olokoba AB, Obateru OA, Bojuwoye MO, et al.
Indications and findings at colonoscopy in Ilorin,
Nigeria. Nigeria Medical J 2013; 54: 111 114.
doi: 10.4103/0300-1652.110044
Aliyu S, Ningi AB and Babayo UD. The Burden
of Colorectal Cancers in Nigeria: Patterns and
Presentations in North-Eastern Nigeria. J Cancer
Research and Oncobiology 2020; 3(1): 128. doi:
31021/jcro.20203128
Benjamin EO and Omoareghan ID. Colorectal
Cancer in Nigeria: Changing Trends and Clinical
Phenotype. J Cancer Sci Ther 2019; 11: 287-291.
Dakubo JCB, Naaeder SB, Tettey Y and Gyasi
RK. Colorectal Carcinoma: An Update of Current
Trends in Accra. West African J Medicine 2010;
(3): 178–183. doi: 10.4314/wajm.v29i3.68218
Cronjé L, Paterson AC and Becker PJ. Colorectal
cancer in South Africa: A heritable cause
suspected in many young black patients. South
African Med J 2009; 99(2): 103-106. PMID:
Medhin LB, Achila OO, Abraham AT, et al.
Incidence of colorectal cancer in Eritrea: Data
from the National Health Laboratory, 2011 2017.
PLoS One 2019;14:e0224045. doi: 10.1371/
journal.pone. 0224045.
Katsidzira L, Gangaidzo I, Thomson S, et al.
The shifting epidemiology of colorectal cancer
in sub-Saharan Africa. Lancet Gastroenterol
Hepatol 2017; 2; 377 383.
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I and Jemal A, Bray F. Global
patterns and trends in colorectal cancer incidence
and mortality. Gut 2017; 66: 683–691. doi:
1136/gutjnl-2015-310912
Graham A, Adeloye D, Grant L, Theodoratou E
and Campbell H. Estimating the incidence of
colorectal cancer in Sub–Saharan Africa: A
systematic analysis. J Global Health 2012; 2(2):
doi: 10.7189/jogh.02.020204.
Richman S and Adlard J. Left and right sided
large bowel cancer. BMJ 2002; 24: 931-932. doi:
1136/bmj.324.7343.931.
Hamilton W, Lancashire R, Sharp D, et al. T.
The importance of anaemia in diagnosing
colorectal cancer: a case-control study using
electronic primary care records. Br J Cancer
; 98(2): 323-327. doi:10.1038/sj.bjc.6604165.
Gonzalez-Hermoso F, Perez-Palma J, MarchenaGomez J, Lorenzo-Rocha N and Medina-Arana
V. Can early diagnosis of symptomatic colorectal
cancer improve the prognosis. World J
Surg 2004; 28: 716–720. doi: 10.1007/s00268-004-
-7238
Stapley S, Peters TJ, Sharp D and Hamilton W.
The mortality of colorectal cancer in relation to
the initial symptom and to the duration of
symptoms: a cohort study in primary care. Br J
Cancer 2006; 95: 1321–1325. doi: 10.1038/
sj.bjc.6603439.
Lee GH, Malietzis G, Askari A, et al. Is rightsided Colon cancer different to left-sided
colorectal Cancer? - a systematic review. Eur J
Surg Oncol 2015 ; 41: 300-308. doi: 10.1016/
j.ejso.2014.11.001
Nawa T, Kato J, Kawamoto H, et al. Differences
between right- and left-sided colon cancer in
patient characteristics, cancer morphology and
histology. J Gastroenterol Hepatol.
;23(3):418-423. doi: 10.1111/j.1440-
2007.04923.x
AO Oluyemi, E Odeghe and O Owoseni
Oribabor FO, Adebayo BO, Aladesanmi T, and
Akinola DO. Anatomical sites of colorectal
cancer in a semi-urban Nigerian hospital: is there
a true rightward shift. East Afr Med J 2013; 90(8):
-52. PMID: 26866111
Anyanwu SN. Colorectal adenocarcinoma in
Eastern Nigeria: Subsite distribution and surgical
treatment patterns. J Clin Oncol 2012;
(Suppl;abstr e1 4III)